Results
1 -
10 of
35Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A-834735, cathinone derivative 4-methoxy-??-PVP, and phenethylamine derivative 4-methylbuphedrine from illegal products, Forensic Toxicology Estimation of the antioxidant effect of the nootropic dipeptide Noopept on the model of Fe2+-induced chemiluminescence of lipoproteins of human serum in vitro, Neurochemical Journal Noopept pharmacokinetics after intravenous administration of a lyophilized medicinal form in rats, Pharmaceutical Chemistry Journal NMDA component in the effects of piracetam and new nootropic peptide GVS-111 on the neocortical and hippocampal EEG in conscious rats, Bulletin of Experimental Biology and Medicine Semax prevents the death of tyrosine hydroxylase-positive neurons in a mixed neuroglial cell culture derived from the embryonic rat mesencephalon in a model of 6-hydroxydopamine-induced neurotoxicity, Neurochemical Journal Theoretical grounds and technologies for dipeptide drug development, Russian Chemical Bulletin The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-l-prolylglycine, European Journal of Drug Metabolism and Pharmacokinetics